María Alejandra Ríos González , Natalia Sánchez Coronel , Dayra Constanza Rojas Duran , William Mauricio Acero Moreno , Lorena García Agudelo
{"title":"Lesiones por animal ponzoñoso, raya de agua dulce: serie de casos","authors":"María Alejandra Ríos González , Natalia Sánchez Coronel , Dayra Constanza Rojas Duran , William Mauricio Acero Moreno , Lorena García Agudelo","doi":"10.1016/j.mcpsp.2024.100478","DOIUrl":"10.1016/j.mcpsp.2024.100478","url":null,"abstract":"<div><h3>Introduction</h3><div>The toxin produced by the freshwater stingray has a histolytic, anaphylactic and highly painful effect.</div></div><div><h3>Objective</h3><div>To present a series of clinical cases of accident with a poisonous animal, the stingray, and its clinical and epidemiological characterization.</div></div><div><h3>Results</h3><div>32 study series, 87,50% male and 12,50% female, age range 7-74 years, mean was 40,59 years, 59,38% were from rural areas and 40,62% urban, 34,37% consulted in the first 24 hours after the event, from one day to seven days 6,25%, from seven to 15 days 15,62%, and more than 15 days 43,75%, lesion in foot 53,13%, in neck of foot 21,87%, in leg 25%, symptoms presented: pain 100%, 71,87% signs of local infection, 59,37% purulent discharge, 56,25% lesion with necrosis. Complications: 9,37% compartment syndrome, 43,75% abscess, 12,50% osteomyelitis, 59,37% coverage defect. The range of surgical procedures performed per patient was 1-7. Isolation 83,33% gram negative, 93,75% in-hospital management and 6,25% were referred due to the severity of the lesions, mortality in this study was 3,12%.</div></div><div><h3>Conclusion</h3><div>Fluvial stingray causes serious lesions in lower limbs that cause prolonged hospital stays, multiple surgical procedures, large coverage defects that merit the investment of high-tech materials and reconstructive plastic surgery.</div></div>","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":"8 1","pages":"Article 100478"},"PeriodicalIF":0.0,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142444719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jacobo Martín Ramos , Francisco Javier Cuevas Fernández , Álvaro Torres Lana , Armando Aguirre Jaime
{"title":"Evolución del paciente hospitalizado con gripe durante 2016–2020 según su estado vacunal","authors":"Jacobo Martín Ramos , Francisco Javier Cuevas Fernández , Álvaro Torres Lana , Armando Aguirre Jaime","doi":"10.1016/j.mcpsp.2024.100471","DOIUrl":"10.1016/j.mcpsp.2024.100471","url":null,"abstract":"<div><h3>Introduction</h3><div>Influenza vaccination is an effective measure to reduce hospital admissions and mortality. The objective of this study is to quantify the effectiveness of influenza vaccination in patients hospitalized for influenza to prevent its evolution to severity, considering other known factors that influence such severity.</div></div><div><h3>Methods</h3><div>Cross-sectional study of the 2016–2017 to 2019–2020 influenza epidemiological seasons with patients hospitalized at the Nuestra Señora de la Candelaria University Hospital in Tenerife diagnosed with influenza. Basic demographic and evolution variables were studied. The criteria for clinical severity used is that established by the Spanish National Epidemiology Center. Using multivariable binary logistic regression, the risk of progression to severity associated with influenza vaccination status was estimated.</div></div><div><h3>Results</h3><div>A total of 1,416 patients were collected. Of whom 50% were women, 56% older than 64 years, 17% with flu vaccination, 24% evolved to severity, 3% died, 72% treated with oseltamivir, 23% (CI95%: 19–27) not treated with oseltamivir were admitted to the ICU, compared to 1.5% (CI95%: 1–2) treated, 25% (CI95%: 23–28) of the non-vaccinated patients developed severity, compared to 18% (CI95%: 13–23) of the vaccinated. The odds ratio (OR) to severe evolution was 1.6 (CI95%: 1.1–2.2) for those not vaccinated.</div></div><div><h3>Conclusions</h3><div>Patients hospitalized for influenza who have not received influenza vaccination have a more than double the risk of a serious evolution of influenza compared to correctly vaccinated patients. The combination of oseltamivir and vaccination reduces their admission to the ICU by almost a fifth.</div></div>","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":"8 1","pages":"Article 100471"},"PeriodicalIF":0.0,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142444718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
María G. Moreno-Treviño, David I. Orozco-Pasadas, José F. Yañez-Mijares, Ma. G. Treviño-Alanís, Gerardo Rivera-Silva
{"title":"Lyme disease: An ultrastructural analysis","authors":"María G. Moreno-Treviño, David I. Orozco-Pasadas, José F. Yañez-Mijares, Ma. G. Treviño-Alanís, Gerardo Rivera-Silva","doi":"10.1016/j.mcpsp.2024.100480","DOIUrl":"10.1016/j.mcpsp.2024.100480","url":null,"abstract":"","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":"8 1","pages":"Article 100480"},"PeriodicalIF":0.0,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142432831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Miguel Saro-Buendía , Catalina Bancalari Díaz , Maria Dolores Sánchez-Alcón , Carlos de Paula Vernetta , Joan Carreres Polo , Miguel Armengot Carceller
{"title":"Schwannoma del nervio facial con afectación temporal y extratemporal","authors":"Miguel Saro-Buendía , Catalina Bancalari Díaz , Maria Dolores Sánchez-Alcón , Carlos de Paula Vernetta , Joan Carreres Polo , Miguel Armengot Carceller","doi":"10.1016/j.mcpsp.2024.100476","DOIUrl":"10.1016/j.mcpsp.2024.100476","url":null,"abstract":"","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":"8 1","pages":"Article 100476"},"PeriodicalIF":0.0,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142425657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"¿La combinación dolutegravir y rifampicina en los pacientes no incluidos en los ensayos clínicos es también eficaz y segura en el binomio VIH-infección micobacteriana? Casos de la práctica clínica","authors":"Sara Fontserè Recuenco , Rafael Luque-Márquez","doi":"10.1016/j.mcpsp.2024.100472","DOIUrl":"10.1016/j.mcpsp.2024.100472","url":null,"abstract":"<div><h3>Introduction</h3><div>Mycobacterial infections and HIV is still a relevant topic. Rifampicin complicates antiretroviral drugs management, influencing the prognostic of both conditions. Dolutegravir is a first option drug, but rifampicin diminishes its levels. Doubling dolutegravir doses until two weeks after completing rifampicin treatment has good results. Our goal is to confirm in our daily practice the efficacy and safety of this scheme.</div></div><div><h3>Methods</h3><div>Eighteen HIV patients were included with mycobacterial infections. Rifampicin was administered with dolutegravir twice a day as commented. Viral suppression and mycobacterial curation were analyzed until the end of the follow-up.</div></div><div><h3>Results</h3><div>Thirteen from 18 were men, 46 years (interquartile range [IQR]: 38–49), diagnosed of HIV or treated since 1.8 years (IQR: 0.1–12), presenting mainly disseminated mycobacterial infections (11 of 18 cases). From which completed follow-up, 91.6% achieved mycobacterial curation (11 of 12) and 92.9% viral load suppression (13 of 14).</div></div><div><h3>Conclusion</h3><div>The treatment of rifampicin with adjusted dolutegravir doses seems to be a proper combination even in severe immunosuppresed population.</div></div>","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":"8 1","pages":"Article 100472"},"PeriodicalIF":0.0,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142425618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Miguel Saro-Buendía MD , Raúl Mellídez Acosta MD , Diego Collado Marín MD , María Lucía Escabias Criado MD , Carlos de Paula Vernetta MD PhD , Miguel Armengot Carceller MD PhD
{"title":"Elongated uvula and chronic pharyngitis","authors":"Miguel Saro-Buendía MD , Raúl Mellídez Acosta MD , Diego Collado Marín MD , María Lucía Escabias Criado MD , Carlos de Paula Vernetta MD PhD , Miguel Armengot Carceller MD PhD","doi":"10.1016/j.mcpsp.2024.100473","DOIUrl":"10.1016/j.mcpsp.2024.100473","url":null,"abstract":"","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":"8 1","pages":"Article 100473"},"PeriodicalIF":0.0,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142322284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gina Rognoni Amrein , Pau Benet Bertran , Antoni Castro Salomó , Carmen Gomar Sancho , Rosa Villalonga Vadell , Jose Zorrilla Riveiro
{"title":"La simulación clínica en la educación médica. Ventajas e inconvenientes del aprendizaje al lado del paciente y en entorno simulado","authors":"Gina Rognoni Amrein , Pau Benet Bertran , Antoni Castro Salomó , Carmen Gomar Sancho , Rosa Villalonga Vadell , Jose Zorrilla Riveiro","doi":"10.1016/j.mcpsp.2024.100459","DOIUrl":"10.1016/j.mcpsp.2024.100459","url":null,"abstract":"<div><div>Clinical Simulation (SC) in Medicine is growing and is currently complementary to conventional learning, both approaches being necessary. There is evidence and is widely accepted by the scientific community. It offers educational and evaluative advantages, allowing trough critical analysis, a safe practice, with equal opportunities for participants, and promoting both technical and humanistic competencies. Technological advances provide an opportunity by facilitating more realistic scenarios and repetitive practice. Despite economic challenges, Clinical Simulation contributes to the training of professionals in a more complete, equitable and safe way.</div></div>","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":"7 4","pages":"Article 100459"},"PeriodicalIF":0.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S260392492400034X/pdfft?md5=ad6bb7bcf2d3de0c574d8d30a4f072dc&pid=1-s2.0-S260392492400034X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Artificial intelligence in action: Improving breast disease management through surgical robotics and remote monitoring","authors":"Marwan Al-Raeei","doi":"10.1016/j.mcpsp.2024.100470","DOIUrl":"10.1016/j.mcpsp.2024.100470","url":null,"abstract":"<div><h3>Objectives</h3><p>This article aims to discuss the transformative impact of artificial intelligence (AI) on the identification and management of breast diseases, with a specific focus on breast cancer.</p></div><div><h3>Materials and methods</h3><p>Healthcare providers have integrated AI technologies such as surgical robots and remote monitoring systems to improve the accuracy and efficiency of breast disease diagnosis and treatment.</p></div><div><h3>Results</h3><p>Surgical robots equipped with AI algorithms provide real-time guidance to surgeons, analyze imaging data, and ensure precise procedures for better outcomes in breast cancer surgeries. AI-driven remote monitoring systems allow for close monitoring of patient health data, disease progression prediction, and personalized treatment recommendations.</p></div><div><h3>Conclusions</h3><p>The incorporation of AI technology into healthcare practices for breast diseases has revolutionized patient care delivery, enhancing outcomes, promoting patient engagement, and improving overall quality of care. These advancements offer personalized and tailored healthcare strategies that meet the unique needs of each patient, reshaping the healthcare industry.</p></div>","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":"7 4","pages":"Article 100470"},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2603924924000454/pdfft?md5=9830d5236888bdab5c5e4dda219d8551&pid=1-s2.0-S2603924924000454-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142148498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}